
Clinical Development Plans: why Biotech and Big Pharma might take different approaches
A Talk by Nelson Kinnersley (Founder and Director, Octa Consulting Services Ltd)
About this Talk
Drawing on experience in crafting Clinical Development Plans (CDPs) for both large pharma and biotech firms, this presentation explores how CDP structures vary based on company strategy. We’ll discuss reasons for these differences and suggest ways statisticians can actively shape robust CDPs that align with company goals.